| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥347.4B | ¥341.1B | +1.8% |
| Operating Income | ¥44.4B | ¥46.8B | -5.1% |
| Ordinary Income | ¥50.5B | ¥52.3B | -3.5% |
| Net Income | ¥37.3B | ¥38.3B | -2.8% |
| ROE | 9.5% | 10.1% | - |
FY2026 Q3 consolidated results showed revenue of 347.4B yen (YoY +1.8%) with operating income of 44.4B yen (YoY -5.1%), indicating a revenue growth accompanied by profit margin compression pattern. Ordinary income declined to 50.5B yen (YoY -3.5%) and net income reached 37.3B yen (YoY -2.8%). Operating margin contracted to 12.8% from prior year's 13.7%, representing approximately 90 basis points of compression. Non-operating income of 8.0B yen, including equity method gains of 5.2B yen and FX gains of 1.1B yen, partially offset operating profit pressure. The company maintains strong liquidity with cash and deposits of 91.1B yen and current ratio of 354.8%, though working capital efficiency concerns emerged with elevated inventory levels and extended receivables collection periods. Long-term borrowings increased substantially by 13.0B yen (+151.5%) YoY to 21.6B yen, aligned with construction in progress expansion, suggesting ongoing capital deployment for facility investments.
Revenue increased 1.8% YoY to 347.4B yen, driven by steady demand in the chemical pump business. Cost of sales rose to 206.2B yen, resulting in gross profit of 141.2B yen with gross margin of 40.6%, representing approximately 60 basis points compression from implied prior year margin. The margin pressure primarily stemmed from product mix effects and input cost increases. Selling, general and administrative expenses reached 96.7B yen, representing 27.8% of revenue, up from approximately 26.9% in the prior year. The disproportionate increase in SGA expenses relative to revenue growth was the principal driver of operating income decline to 44.4B yen (YoY -5.1%). Operating margin contracted 90 basis points to 12.8% as fixed cost absorption deteriorated with modest top-line growth.
Non-operating income contributed positively with equity method investment gains of 5.2B yen, interest and dividend income totaling 0.9B yen, and FX gains of 1.1B yen. Non-operating expenses of 2.0B yen included interest expenses of 0.6B yen. The net non-operating contribution of approximately 6.0B yen supported ordinary income to 50.5B yen, though still down 3.5% YoY. Extraordinary items were minimal at 0.1B yen gain, resulting in profit before tax of 50.6B yen. After income tax expense of 13.3B yen (effective tax rate of 26.3%) and non-controlling interests of 0.6B yen, net income attributable to owners reached 37.3B yen. The performance pattern represents revenue up accompanied by profit down, driven by margin compression from elevated SGA expenses and modest gross margin deterioration.
The company operates a single segment in chemical pump business, therefore segment-level analysis is not applicable.
[Profitability] ROE of 9.5% exceeded the manufacturing industry median of 5.8%, indicating above-average return generation. Operating margin of 12.8% surpassed industry median of 8.9% by 390 basis points, demonstrating competitive positioning in operational efficiency despite quarterly compression. Net profit margin of 10.7% significantly exceeded industry median of 6.5%, reflecting strong bottom-line profitability supported by non-operating income contributions. [Cash Quality] Cash and deposits of 91.1B yen provide 7.5x coverage of short-term borrowings of 12.1B yen, ensuring robust liquidity. Short-term investment securities of 0.8B yen supplement liquid assets. Working capital quality shows concerns with receivables of 80.5B yen and inventories totaling 62.2B yen in finished goods, 43.6B yen in raw materials, and 27.7B yen in work in process, suggesting extended cash conversion cycles. [Investment Efficiency] Asset turnover of 0.64 exceeded industry median of 0.56, indicating efficient asset utilization. Return on assets of 6.8% substantially exceeded industry median of 3.4%, demonstrating superior asset productivity. Return on invested capital metrics reflect efficient capital deployment despite working capital headwinds. [Financial Health] Equity ratio of 71.7% exceeded industry median of 63.8%, indicating conservative capital structure. Current ratio of 354.8% substantially exceeded industry median of 287%, providing ample short-term liquidity cushion. Debt-to-equity ratio of 0.09 reflects minimal financial leverage with total interest-bearing debt of 33.7B yen against total equity of 391.7B yen.
Cash and deposits increased 5.8B yen YoY to 91.1B yen, reflecting operating profit generation despite working capital headwinds. Trade receivables of 80.5B yen represent extended collection periods, while inventories across finished goods (62.2B yen), raw materials (43.6B yen), and work in process (27.7B yen) totaling 133.5B yen indicate inventory management challenges that constrain operating cash generation. Current assets expanded to 368.9B yen with current liabilities of 104.0B yen, maintaining current ratio of 354.8% and demonstrating strong liquidity buffer. Long-term borrowings increased substantially by 13.0B yen to 21.6B yen, aligned with construction in progress expansion evidenced by property, plant and equipment reaching 93.9B yen, suggesting capital deployment toward facility investments. Investment securities of 25.5B yen and goodwill of 18.7B yen reflect strategic equity investments and past acquisitions. The balance sheet structure indicates cash accumulation capacity despite working capital intensity, with financing activities supporting growth capital expenditure while maintaining conservative leverage profile.
Ordinary income of 50.5B yen versus operating income of 44.4B yen indicates non-operating net contribution of approximately 6.1B yen, comprising primarily equity method gains of 5.2B yen from associated companies, interest and dividend income of 0.9B yen, and FX gains of 1.1B yen. Non-operating income represents 2.3% of revenue, consisting of recurring elements from strategic investments and financial income alongside transactional FX effects. The equity method gains demonstrate value contribution from affiliated entities, supporting earnings stability beyond core operations. Interest expenses of 0.6B yen remained modest relative to borrowing levels, reflecting favorable financing costs. Extraordinary items were negligible at 0.1B yen, confirming earnings were not materially affected by one-time factors. The 26.3% effective tax rate aligns with statutory expectations. Comprehensive income of 32.4B yen fell below net income of 37.3B yen due to FX translation adjustment losses of 3.7B yen, remeasurement losses on defined benefit plans of 0.9B yen, and share of OCI of equity method investees of negative 0.2B yen, reflecting unrealized foreign currency headwinds. The earnings composition indicates solid recurring profit quality with meaningful contributions from non-core activities, though working capital management concerns warrant monitoring for sustained cash-backed earnings quality.
Full-year guidance projects revenue of 484.4B yen (YoY +5.8%), operating income of 61.6B yen (YoY +5.4%), and ordinary income of 66.0B yen (YoY +1.3%). Q3 cumulative progress rates stand at 71.7% for revenue, 72.1% for operating income, and 76.5% for ordinary income against full-year targets. These progress rates align with or slightly exceed the standard 75% benchmark for Q3, suggesting the company remains on track to achieve full-year guidance. The implied Q4 performance requires revenue of 137.0B yen, operating income of 17.2B yen, and ordinary income of 15.5B yen. The sequential acceleration in revenue growth from Q3's 1.8% to achieve full-year 5.8% target implies stronger Q4 demand or project deliveries. Operating margin improvement is embedded in guidance, requiring cost control and gross margin recovery in the final quarter. Forecast assumptions note that projections are based on currently available information and reasonable assumptions, with actual results subject to variation from multiple factors. Contract liabilities of 7.0B yen provide limited forward revenue visibility, representing approximately 1.4% of annual revenue guidance, suggesting reliance on near-term order intake for Q4 target achievement.
The company paid an interim dividend of 25.00 yen per share for Q2. Full-year dividend forecast stands at 41.00 yen per share, implying a year-end dividend of 16.00 yen per share. Based on full-year net income guidance of 47.9B yen and average shares outstanding of 22,160K shares, projected EPS reaches 215.82 yen, yielding a payout ratio of 19.0% on forecast basis. The conservative payout ratio provides substantial headroom for dividend sustainability and potential future increases. Using Q3 cumulative net income of 37.3B yen annualized perspective, the payout ratio calculates to approximately 43.0%, still maintaining comfortable coverage. No share buyback programs were disclosed in the current period. Cash reserves of 91.1B yen and strong operating cash generation capacity support dividend payment capacity without liquidity concerns. The dividend policy demonstrates management's commitment to shareholder returns while preserving financial flexibility for growth investments, as evidenced by concurrent facility capital expenditure programs.
Working capital deterioration poses material cash flow risk, with extended inventory turnover and receivables collection periods constraining operating cash conversion. The elevated inventory level of 133.5B yen across finished goods, raw materials, and work in process, combined with trade receivables of 80.5B yen, indicates cash conversion cycle extension that could pressure liquidity if demand softens or payment terms deteriorate further. SGA expense growth outpacing revenue expansion threatens margin sustainability, with SGA ratio increasing to 27.8% from 26.9% YoY. Continued fixed cost deleverage without corresponding revenue acceleration would further compress operating margins below the company's historical performance levels and competitive positioning. Long-term borrowings increased 151.5% YoY to 21.6B yen, aligned with construction in progress expansion, introducing refinancing and project execution risks. If facility investments experience cost overruns, construction delays, or fail to generate projected returns, debt servicing capacity and return on invested capital could deteriorate. Goodwill of 18.7B yen and intangible assets of 25.4B yen representing past acquisitions face potential impairment risk if acquired business units underperform strategic assumptions or market conditions deteriorate.
[Industry Position] (Reference - Proprietary Analysis)
The company demonstrates superior profitability metrics relative to the manufacturing industry benchmark. ROE of 9.5% substantially exceeds industry median of 5.8%, placing the company in the upper performance quartile. Operating margin of 12.8% surpasses industry median of 8.9% by 390 basis points, reflecting competitive advantages in pricing power and operational efficiency. Net profit margin of 10.7% significantly exceeds industry median of 6.5%, supported by both strong core margins and non-operating income contributions. Asset turnover of 0.64 exceeds industry median of 0.56, indicating efficient capital utilization. Revenue growth of 1.8% YoY trails industry median of 2.8%, suggesting relative market share stability rather than aggressive expansion.
Financial health metrics reflect conservative positioning. Equity ratio of 71.7% exceeds industry median of 63.8%, demonstrating lower financial risk profile. Current ratio of 354.8% substantially surpasses industry median of 287%, providing exceptional liquidity buffer. The company operates with minimal leverage compared to industry norms. Working capital efficiency shows mixed signals, with inventory turnover and receivables collection warranting attention relative to industry standards. The company's single-segment chemical pump focus provides operational clarity but limits diversification benefits relative to broader manufacturing peers.
(Industry: Manufacturing, N=105 companies, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Superior profitability positioning with ROE of 9.5% and operating margin of 12.8% substantially exceeding manufacturing industry medians of 5.8% and 8.9% respectively demonstrates sustainable competitive advantages in the chemical pump business, though Q3 margin compression of 90 basis points to 12.8% requires reversal through SGA expense control and gross margin recovery to maintain premium valuation. Conservative financial structure with equity ratio of 71.7% and current ratio of 354.8% both exceeding industry benchmarks, combined with cash reserves of 91.1B yen providing 7.5x coverage of short-term debt, positions the company to weather demand volatility and fund growth investments, though the 151.5% increase in long-term borrowings to 21.6B yen aligned with facility expansion requires monitoring of project execution and return realization. Working capital efficiency deterioration evidenced by elevated inventory levels of 133.5B yen and extended receivables represents the most material near-term risk to cash flow generation and return on invested capital, necessitating operational improvements in inventory turnover and collection management to sustain the company's strong cash conversion historically and support the modest 19.0% dividend payout ratio on forecast basis.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.